Where does NeuroLogica Corp. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), NeuroLogica Corp. ranks #24,868 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does NeuroLogica Corp. hold?

NeuroLogica Corp. holds 11 US utility patents granted between 2015 and 2024, spanning 4 technology areas.

What is NeuroLogica Corp.'s Innovation Score?

NeuroLogica Corp. has an Innovation Score of 34.7 out of 100 (49th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does NeuroLogica Corp. focus on?

NeuroLogica Corp.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 11 patents, ranking #1,592 of 7,127 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is NeuroLogica Corp.'s patent grant rate increasing or decreasing?

NeuroLogica Corp.'s recent grant velocity is -43% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for NeuroLogica Corp.'s patents?

NeuroLogica Corp.'s patents average 15.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the NeuroLogica Corp. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

NeuroLogica Corp.

USPTO PatentsView assignee record - 11 granted patents across 4 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neurologica ranks #24,868 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 4 technology areas.

#24,868
of 49,997 US assignees by volume: 49th percentile
by Innovation Score (34.7/100): 15.1
avg claims per patent: -43%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24868 · US Corporation #24,868 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,868/49,997
PHOTO-FINISH Neone
CPC-NARROW A61B · 4 areas
INNOV-THIN 34.7/100
CLAIMS-RICH 15.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -43% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Neone, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neurologica’s 34.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (25%) Velocity 10.0 pts (29%) Breadth 7.1 pts (20%) Claim depth 9.1 pts (26%)

Qualcomm Incorporated · highest

85
NeuroLogica · this assignee

35
3D Lighting… · lowest

7

What this shows Neurologica's Innovation Score is 34.7/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Neurologica?

Each dot is one of Neurologica’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neurologica’s own 15.1 claims/patent is ABOVE the 12.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Neurologica vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neurologica's grants concentrate

NeuroLogica Corp. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2019. By volume, Neurologica sits between Neone, Inc. and NewBlue, Inc..

Neurologica's three-year grant acceleration

NeuroLogica Corp. shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Neone

11
Neoz Pty

11
Neptune Trading

11
Neul

11
Neusch Innovations

11
Nevion AS

11
New Shicoh Techno…

11
Newblue

11
Neurologica ◀

11

What this shows NeuroLogica holds 11 patents at rank #24,885, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near NeuroLogica

By rank, the assignees closest to #24,885 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in NeuroLogica's primary technology class.

Neurologica's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 49th percentile higher than 49% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

NeuroLogica Corp. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	36.4%
2017	2	18.2%
2019	1	9.1%
2020	1	9.1%
2022	2	18.2%
2024	1	9.1%

Which technologies does NeuroLogica Corp. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 11

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

G21K - Techniques FOR Handling Particles OR Ionising Radiation NOT Otherwise Provided FOR; Irradiation DEVICES; Gamma RAY OR X-ray Microscopes 1

B60B - Vehicle Wheels ; CASTORS; Axles FOR Wheels OR CASTORS; Increasing Wheel Adhesion 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

NeuroLogica Corp.'s patent record in context - here's where to go next.

NeuroLogica Corp.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #24,868 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare NeuroLogica Corp. against Neone, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.